Local warehouses. Local dispatch. Australia · Canada · USA
Tissue research comparison

BPC-157 vs GHK-Cu.
Different materials, different measurements.

A plain-English comparison of peptide identity, selected tissue and collagen research, and the catalogue content behind a precise enquiry.

BPC-157 and GHK-Cu are different research materials. BPC-157 is a synthetic peptide with 15 amino acids. GHK-Cu is the copper complex of GHK, a three-amino-acid peptide. Both appear in tissue-research discussions, but their names and the experiments behind them should stay separate. BPC-157 primary study · GHK-Cu primary study.

Aurelis lists BPC-157 10 mg and GHK-Cu 50 mg / 100 mg per unit. This guide compares their identities and selected study questions, rather than treating a shared research category as evidence that they are interchangeable.

BPC-157 vs GHK-Cu at a glance

Selected research settings and current Aurelis entries
CompareBPC-157GHK-Cu
IdentitySynthetic 15-amino-acid peptideGlycyl-L-histidyl-L-lysine complexed with copper(II)
Selected research settingRat tendon samples and cultured tendon fibroblastsFibroblast cultures examining collagen and surrounding matrix
Example measurementsCell outgrowth, movement, survival and growth-hormone-receptor expressionCollagen synthesis and matrix-remodelling signals
Listed content per unit10 mg50 mg / 100 mg
Identity detail to retainFull BPC-157 name and accepted molecular specificationThe Cu designation and accepted copper-complex specification

BPC-157: what did the tendon-cell experiments measure?

In a 2011 paper, Chang and colleagues studied rat Achilles-tendon samples and cells grown from that tissue. They reported increased cell outgrowth from tendon samples, greater movement and spreading of cultured cells, and improved cell survival under an experimental oxidative stress. They did not observe a direct increase in multiplication of the cultured tendon fibroblasts. Read the tendon-cell paper.

A 2014 study examined a different question in rat tendon fibroblasts: growth-hormone-receptor expression. BPC-157 increased the measured receptor expression. When growth hormone was added to the pretreated cells, the researchers observed increased proliferation and activation of the JAK2 signalling pathway. Read the receptor-expression paper.

These are related research questions, but cell movement, cell multiplication and receptor expression are distinct measurements. Keep the experimental setting attached to each result when reading recovery-related discussions.

GHK-Cu: why collagen and matrix research?

Fibroblasts help produce the structural material around cells. In a 1988 study, Maquart and colleagues reported increased collagen synthesis in fibroblast cultures exposed to GHK-Cu. The change was independent of a change in cell number. This is a specific collagen-production finding in a laboratory setting. Read the collagen-synthesis paper.

A later fibroblast-culture study examined matrix remodelling: the processes that change the material surrounding cells. GHK-Cu increased the measured level of MMP-2, an enzyme involved in that process. Copper ions reproduced the effect; GHK alone did not. This makes the copper designation relevant when matching a name to a paper. Read the matrix-remodelling paper.

Does this show which peptide is better for recovery?

The selected papers did not test BPC-157 against GHK-Cu in one experiment. Tendon-cell movement and collagen synthesis are different endpoints. Their results cannot establish a head-to-head recovery ranking, an expected cosmetic result or the performance of an offered Aurelis batch.

For a useful reading note, record four details together: the exact material, the cells or tissue studied, the measurement and the comparison group. Our individual BPC-157 tendon guide and GHK-Cu matrix guide provide more context. The separate GHK vs GHK-Cu comparison focuses on the copper-complex distinction.

Why 10 mg, 50 mg and 100 mg are not an activity ranking

The catalogue values describe listed content per unit. GHK-Cu 100 mg lists twice the content of its 50 mg entry, but neither number measures biological effect. Comparing the amount of one molecule with another does not compare their activity.

Concentration also needs a defined volume and reporting basis. The content figures here do not supply those fields or describe an amount to use. See the content and concentration guide for the distinction.

Keep standalone entries separate from blends and formats

A blend entry is a separate specification. GLOW and KLOW source lines abbreviate ingredients as GHK and BPC; those abbreviations alone do not confirm that the components match the standalone GHK-Cu and BPC-157 entries. The blend guide retains the written amounts and unresolved details, including the KLOW total discrepancy.

Both vials and pen-style kits remain part of the Aurelis format enquiry. Confirm the presentation, contents and packaging for the selected entry, rather than inferring a finished formulation from its image.

Send a focused enquiry

Include BPC-157 10 mg or GHK-Cu 50 mg / 100 mg, the requested quantity, preferred presentation and destination in Australia, Canada or the USA. Ask the team to confirm current local availability and supply the matching identity, content and batch records.

Enquire about BPC-157 or GHK-Cu or email sales@aurelispeptides.com.

Primary research sources

  1. Chang et al., Journal of Applied Physiology, 2011 — rat tendon samples and cultured tendon fibroblasts.
  2. Chang et al., Molecules, 2014 — growth-hormone-receptor expression in rat tendon fibroblasts.
  3. Maquart et al., FEBS Letters, 1988 — GHK-Cu and collagen synthesis in fibroblast cultures.
  4. Siméon et al., Life Sciences, 2000 — GHK-Cu, GHK and copper-ion comparisons in matrix-remodelling research.

Connect with Aurelis

Your next enquiry
starts with the details.

Tell us the compound, listed content, preferred presentation and destination. Our team can discuss local availability and the documentation for your selected material.